Norwegian connection helps grow sustainable roots for Sub-Saharan aquaculture

Since 2014, the Norwegian University of Life Sciences (NMBU) has been working in Sub-Saharan Africa to train the region’s next generation of aquaculture professionals on the key facets of fish-health management.

FHFweb_Mutoloki NMBU

Norwegian connection helps grow sustainable roots for Sub-Saharan aquaculture

Health & Welfare

PHQweb Vaccine Work in Progress2 NT 182179028

Vaccine ‘work in progress’ in major aquaculture markets, Part 2: Tilapia

Nile tilapia is now the second most farmed fish worldwide, in part due to its adaptability. It is, however, susceptible to a number of diseases.

PHQweb Mycobacteriosis 275017732

Mycobacteriosis could prove growing problem in aquaculture

Intensification of aquaculture and domestication of wild species are leading to an increased prevalence of mycobacteriosis in farmed aquatic invertebrates, according to a review of the disease’s emergence by an international team of researchers.

PropVacc ExAd article

Why fish vaccines are increasingly coming in smaller doses

An interview with Dr Bjørn Brudeseth, PhD, PHARMAQ

PHQweb TilipiaVirus 353293565

Taming tilapia lake virus requires improved expert collaboration

Tilapia lake virus (TiLV) is an emerging threat to aquaculture, having been discovered in 2014 and now reported in 16 countries.

PHQweb China vaccine 319423369 sr2

China making up for lost time in aquatic vaccine development

China is now responsible for over 70% of global farmed-fish production. Finding appropriate responses to fish disease has not been as rapid, researchers from Huazhong Agricultural University acknowledged — but new options in development suggest that the nation is fast catching up.

FHFweb Ctenolabrus rupestris orkney

Cleaner-fish health risks highlighted as use in aquaculture rises

Cleaner fish have proved an effective alternative method of sea louse control — but their widespread introduction brings with it a new threat of pathogens and parasites, and available treatments are falling short of requirements.